Preview

Cardiovascular Therapy and Prevention

Advanced search

THE ANALYSIS OF CLINICAL, FUNCTIONAL, LABORATORY AND GENETIC PARAMETERS VALUES ON THE CONDITION OF PATIENTS AFTER MYOCARDIAL INFARCTION, AND PROGNOSIS OF INTRAMYOCARDIAL AUTOLOGIC CELL THERAPY EFFECTIVENESS FOR CHRONIC HEART FAILURE

https://doi.org/10.15829/1728-8800-2015-1-23-29

Abstract

Aim. To reveal or rule out an interconnection of the specifics of structure of clinical, functional, laboratory and genetic parameters of patients, who had myocardial infarction, with the effectiveness of intramyocardial autologic cell therapy (IACT).

Material and methods. The study involved 71 patients, 87% of men, with ischemic heart disease and III-IV functional class (NYHA) heart failure at the age 37-76 y.o. (mean age 57,0±0,9 y.o.). The procedure of mobilized mononucleares loading into the blood and clinical effectiveness assessment was done at FSBI "SRICP n.a. E. N. Meshalkin" HM RF (Novosibirsk). The parameters of ischemic anamnesis were studied, left ventricle ejection volume, level of TNF-a and GM-CSF in cell cultures of patients' blood, the amount of CD34+ before and after G-CSFstimulation. The mononucleotide polymorphism of promotor region of cytokine genes studied (TNF-308, TNF-238, TNF-863, IL1B-511, IL1B- 31, IL4-590, IL6-174, IL10-592, IL10-1082), of endothelial growth factor (VEGF+936, VEGF-2578) and of matrix metalloproteinases (MMP2- 1306, MMP3-1171, MMP9-1562).

Results. Among 11 clinical and laboratory parameters, and 14 polymorphic gene areas, just for two genotypes of VEGF in polymorphic position +936 C/T there were significant (p=0,0134) differences revealed for patients groups with and without long-term clinical effect of IACT usage. Amount of information obtained from complex quantitative parameters and genotypic signs increases dramatically (J=4,28-5,25, p<0,001). Also individual values of diagnostic coefficients usually are higher than minimally necessary of the 95% significance of prognosis, with threshold value (±12,8).

Conclusion. Complex laboratory and genetic parameters, segregated into specific combinations have high prognostic value and can be used while developing the criteria of effectiveness evaluation of further cell therapy in CHF patients.

 

About the Authors

V. I. Konenkov
FSBI "SRI of clinical and experimental lymphology" SD RAMS. Novosibirsk, Russia
Russian Federation


O. V. Poveshchenko
FSBI "SRI of clinical and experimental lymphology" SD RAMS. Novosibirsk, Russia
Russian Federation


V. F. Prokofiev
FSBI "SRI of clinical and experimental lymphology" SD RAMS. Novosibirsk, Russia
Russian Federation


A. V. Shevchenko
FSBI "SRI of clinical and experimental lymphology" SD RAMS. Novosibirsk, Russia
Russian Federation


I. N. Kim
FSBI "SRI of clinical and experimental lymphology" SD RAMS. Novosibirsk, Russia
Russian Federation


N. A. Bondarenko
FSBI "SRI of clinical and experimental lymphology" SD RAMS. Novosibirsk, Russia
Russian Federation


A. M. Karaskov
FSBI "SRI of circulatory pathology n.a. E. N. Meshalkin" of the Healthcare Ministry. Novosibirsk, Russia
Russian Federation


E. V. Pokushalov
FSBI "SRI of circulatory pathology n.a. E. N. Meshalkin" of the Healthcare Ministry. Novosibirsk, Russia
Russian Federation


A. B. Romanov
FSBI "SRI of circulatory pathology n.a. E. N. Meshalkin" of the Healthcare Ministry. Novosibirsk, Russia
Russian Federation


References

1. Bokerija LA, Buziashvili Jul, Mackeplishvili ST, Kamardinov DH. First experience of bone marrow stem cells for regenerative therapy of coronary heart disease. Kardiologija 2004; 44(9): 16-22. Russian (Бокерия Л. А., Бузиашвили Ю. И., Мацкеплишвили С. Т., Камардинов Д.Х. Первый опыт применения стволовых клеток костного мозга для регенерационной терапии ишемической болезни сердца. Кардиология. 2004; 44(9): 16-22).

2. Chang SA, Kang HJ, Lee H.Y et al. Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction for intracoronary cell infusion. Heart 2009; 95(16): 1326-30.

3. Kang HJ, Kim HS, Koo BK, et al. Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial. Am Heart J 2007; 153(2): 237.e1 -8.

4. Kim II, Poveshhenko OV, Bondarenko NA, et al. The influence of morphological and functional properties of mobilized progenitor cells in patients with chronic heart failure on the effectiveness of autologous intramyocardial cell transplantation. Cell Technologies in Biology and Medicine 2014; 2: 117-23. Russian (Ким И.И., Повещенко О. В., Бондаренко Н. А. и др. Влияние морфофункциональных свойств мобилизованных прогениторных клеток пациентов с хронической сердечной недостаточностью на эффективность аутологичной интрамиокардиаль- ной клеточной трансплантации. Клеточные технологии в биологии и медицине 2014; 2: 117-23).

5. Konenkov VI, Poveshhenko OV, Karas'kov AM, Pokushalov EA. Cellular technology treatment of severe chronic heart failure, as an alternative to heart transplantation. I National Congress on Regenerative Medicine 4-6 December 2013. Moscow 2013; 124. Russian (Коненков В. И., Повещенко О. В., Караськов А. М., Покушалов Е. А. Клеточные технологии лечения тяжелой хронической сердечной недостаточности, как альтернатива трансплантации сердца. I Национальный конгресс по регенеративной медицине 4-6 декабря 2013 г. Москва 2013; 124).

6. Konenkov VI, Shevchenko AV, Prokofiev VF, et al. Cytokine gene networks in a personalized prediction of human health and the formation of groups at high risk for disease prevention. Preventive Medicine 2013; 4: 19-26. Russian (Коненков В. И., Шевченко А. В., Прокофьев В. Ф. и др. Цитокиновые генные сети в персонализированном прогнозе состояния здоровья человека и формирования групп высокого риска развития заболеваний для проведения профилактических мероприятий. Профилактическая медицина 2013; 4: 19-26).

7. Konenkov VI, Shevchenko AV, Prokofiev VF, Maksimov VN. Complex cytokine genotypes as a genetic risk factor for myocardial infarction in men Caucasoid

8. population in Russia. Kardiologija 2012; 7: 22-9. Russian (Коненков В. И. Шевченко А.В. Прокофьев В. Ф. Максимов В. Н. Комплекс генотипов цитокинов как гене¬тический фактор риска развития инфаркта миокарда у мужчин европеоидного населения России. Кардиология 2012; 7: 22-9).

9. Weir B. Genetic Data Analysis: Discrete genetic traits. Translation from English. M.: Mir; 1995. Russian (Вейр Б. Анализ генетических данных: Дискретные генетиче¬ские признаки. Пер. с англ. М.: Мир; 1995).

10. Glantz S. Biomedical Statistics. Translation from English. M.: Praktika; 1998. Russian (Гланц С. Медико-биологическая статистика. Пер. с англ. М.: Практика; 1998).

11. Babich PN, Chubenko AV, Lapach SN. Application of modern statistical methods in the practice of clinical research. Third message. Odds ratio: concepts, calculation and interpretation. Ukrainian Medical J 2005; 2(46): 113-9. Russian (Бабич П. Н., Чубенко А. В., Лапач С. Н. Применение современных статистических методов в практике клинических исследований. Сообщение третье. Отношение шансов: понятия, вычисление и интерпретация. Украинский медицинский ж 2005; 2(46): 113-9).

12. Lashkov KV, Poljakov LE. Application of the methods of nonparametric statistics in scientific medical research. In: Statistical methods of research in medicine and health. M.: Medicina 1971; 32-92. Russian (Лашков К. В., Поляков Л. Е. Применение методов непараметрической статистики в научных медицинских исследовани¬ях. В кн.: Статистические методы исследования в медицине и здравоохране¬нии. М.: Медицина 1971; 32-92).

13. Gubler EV. Computational methods of analysis and recognition of pathological processes. L.: Medicina; 1983. Russian (Гублер Е. В. Вычислительные методы анализа и распознавания патологических процессов. Л.: Медицина; 1983).

14. Genes VS. Some simple methods of cyber data diagnostic and physiological studies. M.: Nauka; 1967. Russian (Генес В. С. Некоторые простые методы кибернетической обработки данных диагностических и физиологических исследований. М.: Наука; 1967).

15. Davydenko VV, Gricenko VV, Afanas'ev BV, et al. Intracardiac and other mononuclear cells transplantation of autologous bone marrow in treatment of patients with valvular heart. Vestnik Khirurgii Imeni I. I. Grekova 2007; 166(3): 16-21. Russian (Давыденко В. В., Гриценко В. В., Афанасьев Б. В. и др. Интракардиальная трансплантация мононуклеарных клеток аутологичного костного мозга в ком¬плексном лечении больных с пороками клапанов сердца. Вестник хирургии им. И. И. Грекова 2007; 166(3): 16-21).

16. Perin EC, Dohmann HF, Borojevic R, et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 2004; 110(Suppl. II): 213-8.


Review

For citations:


Konenkov V.I., Poveshchenko O.V., Prokofiev V.F., Shevchenko A.V., Kim I.N., Bondarenko N.A., Karaskov A.M., Pokushalov E.V., Romanov A.B. THE ANALYSIS OF CLINICAL, FUNCTIONAL, LABORATORY AND GENETIC PARAMETERS VALUES ON THE CONDITION OF PATIENTS AFTER MYOCARDIAL INFARCTION, AND PROGNOSIS OF INTRAMYOCARDIAL AUTOLOGIC CELL THERAPY EFFECTIVENESS FOR CHRONIC HEART FAILURE. Cardiovascular Therapy and Prevention. 2015;14(1):23-29. (In Russ.) https://doi.org/10.15829/1728-8800-2015-1-23-29

Views: 720


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)